MFN2 expression was significantly different across LCL groups [F(2,44) = 10.66, p < 0.0005] due to higher expression in AD-N LCLs as compared to CNT [t(44) = 2.60, p = 0.01] and AD-A [t(44) = 4.60, p < 0.0001] LCLs. Here, MFN2 is linked to Alzheimer disease.